Who invested in Genoa Pharmaceuticals?
Genoa Pharmaceuticals's investors include TPG, Novo Holdings, F-Prime Capital, Andera Partners and RiverVest.
United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$63Mraised across 2 rounds since 2012, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by BusinesswireSEC filing: $18M sold, first sale Mar 2017
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Oct 2011
From the SEC filings it signed: 2 on the team.
On the board, as filediHeather W. PrestonJonathan W. LeffKetan W. PatelNaveed W. SiddiqiNiall W. O'DonnellTiba W. Aynechi
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Genoa Pharmaceuticals's investors include TPG, Novo Holdings, F-Prime Capital, Andera Partners and RiverVest.
Genoa Pharmaceuticals has raised $63M across 2 rounds since 2012.
Genoa Pharmaceuticals's most recent round was a Series A of $62M in May 2017.
Its most recent round, $62M in May 2017, is also its largest on record.
Genoa Pharmaceuticals's first round on record, in May 2017, was backed by TPG, Novo Holdings and F-Prime Capital and 2 others.
Genoa Pharmaceuticals's latest named round is a Series A, in May 2017.
Genoa Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.